Skip to main content
SpringerLink
Log in

Effect of an Albumin Infusion Treatment Protocol on Delayed Cerebral Ischemia and Relevant Outcomes in Patients with Subarachnoid Hemorrhage

  • Original work
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background

An institutional management protocol for patients with subarachnoid hemorrhage (SAH) based on initial cardiac assessment, permissiveness of negative fluid balances, and use of a continuous albumin infusion as the main fluid therapy for the first 5 days of the intensive care unit (ICU) stay was implemented at our hospital in 2014. It aimed at achieving and maintaining euvolemia and hemodynamic stability to prevent ischemic events and complications in the ICU by reducing periods of hypovolemia or hemodynamic instability. This study aimed at assessing the effect of the implemented management protocol on the incidence of delayed cerebral ischemia (DCI), mortality, and other relevant outcomes in patients with SAH during ICU stay.

Methods

We conducted a quasi-experimental study with historical controls based on electronic medical records of adults with SAH admitted to the ICU at a tertiary care university hospital in Cali, Colombia. The patients treated between 2011 and 2014 were the control group, and those treated between 2014 and 2018 were the intervention group. We collected baseline clinical characteristics, cointerventions, occurrence of DCI, vital status after 6 months, neurological status after 6 months, hydroelectrolytic imbalances, and other SAH complication. Multivariable and sensitivity analyses that controlled for confounding and considered the presence of competing risks were used to adequately estimate the effects of the management protocol. The study was approved by our institutional ethics review board before study start.

Results

One hundred eighty-nine patients were included for analysis. The management protocol was associated with a reduced incidence of DCI (hazard ratio 0.52 [95% confidence interval 0.33–0.83] from multivariable subdistribution hazards model) and hyponatremia (relative risk 0.55 [95% confidence interval 0.37–0.80]). The management protocol was not associated with higher hospital or long-term mortality, nor with a higher occurrence of other unfavorable outcomes (pulmonary edema, rebleeding, hydrocephalus, hypernatremia, pneumonia). The intervention group also had lower daily and cumulative administered fluids compared with historic controls (p < 0.0001).

Conclusions

A management protocol based on hemodynamically oriented fluid therapy in combination with a continuous albumin infusion as the main fluid during the first 5 days of the ICU stay appears beneficial for patients with SAH because it was associated with reduced incidence of DCI and hyponatremia. Proposed mechanisms include improved hemodynamic stability that allows euvolemia and reduces the risk of ischemia, among others.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2012;43(6):1711–37.

    Article  PubMed  Google Scholar 

  2. Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2014;10(1):44–58. https://doi.org/10.1038/nrneurol.2013.246.

    Article  CAS  PubMed  Google Scholar 

  3. van Lieshout JH, Dibué-Adjei M, Cornelius JF, Slotty PJ, Schneider T, Restin T, et al. An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage. Neurosurg Rev. 2018;41(4):917–30.

    Article  PubMed  Google Scholar 

  4. Maher M, Schweizer TA, Macdonald RL. Treatment of Spontaneous Subarachnoid Hemorrhage: Guidelines and Gaps. Stroke. 2020;1326–32.

  5. Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G. European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35(2):93–112.

    Article  PubMed  Google Scholar 

  6. Suarez JI, Martin RH, Calvillo E, Zygun D, Flower O, Wong GK, et al. Human albumin administration in subarachnoid hemorrhage: results of an international survey. Neurocrit Care. 2014;20(2):277–86.

    Article  CAS  PubMed  Google Scholar 

  7. Suarez JI, Shannon L, Zaida OO, Suri MF, Singh G, Lynch G, et al. Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage. J Neurosurg. 2004;100(4):585–90.

    Article  CAS  PubMed  Google Scholar 

  8. Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, et al. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–90.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Mayer SA, Solomon RA, Fink ME, Lennihan L, Stern L, Beckford A, et al. Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage. Neurosurgery. 1998;42(4):758–9.

    Article  Google Scholar 

  10. Orbegozo Cortés D, Gamarano Barros T, Njimi H, Vincent J-L. Crystalloids versus colloids: exploring differences in fluid requirements by systematic review and meta-regression. Anesth Analg. 2015;120(2):389–402.

    Article  PubMed  Google Scholar 

  11. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247–56.

    Article  CAS  PubMed  Google Scholar 

  12. Quon CY. Clinical pharmacokinetics and pharmacodynamics of colloidal plasma volume expanders. J Cardiothorac Anesth [Internet]. 1988;2(6, Supplement 1):13–23. Available from: https://www.sciencedirect.com/science/article/pii/S0888629688800048.

  13. Vergouwen MDI, Vermeulen M, van Gijn J, Rinkel GJE, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391–5.

    Article  PubMed  Google Scholar 

  14. Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:1–8.

    Article  Google Scholar 

  15. Kleinbaum, David G., Klein M. Survival Analysis—A Self-Learning Text—3rd Edition [Internet]. Springer. 2011. ii. Available from: http://linkinghub.elsevier.com/retrieve/pii/B9780444538154000248

  16. Bhattacharyya HT, Kleinbaum DG, Kupper LL. Applied regression analysis and other multivariable methods. J Am Stat Assoc. 1979;74:732.

    Article  Google Scholar 

  17. Austin PC, Fine JP. Accounting for competing risks in randomized controlled trials: a review and recommendations for improvement. Stat Med. 2017;36(8):1203–9.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133(6):601–9.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Gray RJ. A Class of K-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk. Ann Stat [Internet]. 1988 6;16(3):1141–54. Available from: http://www.jstor.org/stable/2241622.

  20. Scrucca L, Santucci A, Aversa F. Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant. 2010;45(9):1388–95.

    Article  CAS  PubMed  Google Scholar 

  21. Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant. 2007;40(4):381–7.

    Article  CAS  PubMed  Google Scholar 

  22. Gribbons B, Herman J. True and Quasi-Experimental Designs.—Practical Assessment, Research & Evaluation. Pract Assessment, Res Eval [Internet]. 1997;5(14):3–5. Available from: http://pareonline.net/getvn.asp?v=5&n=14.

  23. Rowland MJ, Hadjipavlou G, Kelly M, Westbrook J, Pattinson KTS. Delayed cerebral ischaemia after subarachnoid haemorrhage: Looking beyond vasospasm. Br J Anaesth. 2012;109(3):315–29. https://doi.org/10.1093/bja/aes264.

    Article  CAS  PubMed  Google Scholar 

  24. Obata Y, Takeda J, Sato Y, Ishikura H, Matsui T, Isotani E. A multicenter prospective cohort study of volume management after subarachnoid hemorrhage: circulatory characteristics of pulmonary edema after subarachnoid hemorrhage. J Neurosurg. 2016;125(2):254–63.

    Article  PubMed  Google Scholar 

  25. McLaughlin N, Bojanowski MW, Girard F, Denault A. Pulmonary Edema and Cardiac Dysfunction Following Subarachnoid Hemorrhage. Can J Neurol Sci/J Can des Sci Neurol [Internet]. 2014/12/02. 2005;32(2):178–85. Available from: https://www.cambridge.org/core/article/pulmonary-edema-and-cardiac-dysfunction-following-subarachnoid-hemorrhage/EDCCB69FC8FC750E4E3A4F9304B67857.

  26. Oddo M, Poole D, Helbok R, Meyfroidt G, Stocchetti N, Bouzat P, et al. Fluid therapy in neurointensive care patients: ESICM consensus and clinical practice recommendations. Intensive Care Med. 2018;44(4):449–63. https://doi.org/10.1007/s00134-018-5086-z.

    Article  PubMed  Google Scholar 

  27. Wang L, Li M, Xie Y, Xu L, Ye R, Liu X. Preclinical efficacy of human Albumin in subarachnoid hemorrhage. Neuroscience. 2017;344(January):255–64. https://doi.org/10.1016/j.neuroscience.2016.12.033.

    Article  CAS  PubMed  Google Scholar 

  28. Xie Y, Liu W, Zhang X, Wang L, Xu L, Xiong Y, et al. Human albumin improves long-term behavioral sequelae after Subarachnoid hemorrhage through neurovascular remodeling. Crit Care Med. 2015;43(10):e440–9.

    Article  PubMed  Google Scholar 

  29. Belayev L, Saul I, Huh PW, Finotti N, Zhao W, Busto R, et al. Neuroprotective effect of high-dose albumin therapy against global ischemic brain injury in rats. Brain Res. 1999;845(1):107–11.

    Article  CAS  PubMed  Google Scholar 

  30. Rinkel GJ, Feigin VL, Algra A, van Gijn J. Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2004;(4).

  31. GM I, RL M. The effects of fluid balance and colloid administration on outcomes in patients with aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis. Neurocrit Care [Internet]. 2013;19(2):140–9. Available from: https://pubmed.ncbi.nlm.nih.gov/23715669/.

  32. Audibert G, Steinmann G, de Talancé N, Laurens M-H, Dao P, Baumann A, et al. Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation. Anesth Analg. 2009;108(6):1922–8.

    Article  PubMed  Google Scholar 

  33. Diringer MN, Bleck TP, Hemphill JC, Menon D, Shutter L, Vespa P, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the neurocritical care society’s multidisciplinary consensus conference. Neurocrit Care. 2011;15(2):211–40.

    Article  PubMed  Google Scholar 

  34. Schwartzkopff W, Schwartzkopff B, Wurm W, Frisius H. Physiological aspects of the role of human albumin in the treatment of chronic and acute blood loss. Dev Biol Stand. 1980;48:7–30.

    CAS  PubMed  Google Scholar 

  35. Anetsberger A, Gempt J, Blobner M, Ringel F, Bogdanski R, Heim M, et al. Impact of goal-directed therapy on delayed ischemia after aneurysmal subarachnoid hemorrhage: randomized controlled trial. Stroke. 2020;51(8):2287–96.

    Article  CAS  PubMed  Google Scholar 

  36. Mutoh T, Kazumata K, Terasaka S, Taki Y, Suzuki A, Ishikawa T. Early intensive versus minimally invasive approach to postoperative hemodynamic management after subarachnoid hemorrhage. Stroke. 2014;45(5):1280–4. https://doi.org/10.1161/STROKEAHA.114.004739.

    Article  PubMed  Google Scholar 

  37. Schenck H, Netti E, Teernstra O, De Ridder I, Dings J, Niemelä M, et al. The role of the glycocalyx in the pathophysiology of subarachnoid hemorrhage-induced delayed cerebral ischemia. Front Cell Dev Biol. 2021. https://doi.org/10.3389/fcell.2021.731641.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Becker BF, Jacob M, Leipert S, Salmon AHJ, Chappell D. Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases. Br J Clin Pharmacol. 2015;80(3):389–402.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Aldecoa C, Llau JV, Nuvials X, Artigas A. Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review. Ann Intensive Care. 2020;10(1):1–12. https://doi.org/10.1186/s13613-020-00697-1.

    Article  CAS  Google Scholar 

  40. Bell JD, Rhind SG, Di Battista AP, Macdonald RL, Baker AJ. Biomarkers of glycocalyx injury are associated with delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage: a case series supporting a new hypothesis. Neurocrit Care. 2017;26(3):339–47. https://doi.org/10.1007/s12028-016-0357-4.

    Article  CAS  PubMed  Google Scholar 

  41. Chappell D, Bruegger D, Potzel J, Jacob M, Brettner F, Vogeser M, et al. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx. Crit Care. 2014;18(5):538.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

Centro de Investigaciones Clínicas, Fundación Valle del Lili (institutional research, no external funding).

Author information

Authors and Affiliations

  1. Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia

    Andrés Gempeler & Leidy Gaviria

  2. Department of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Cali, Colombia

    Andrés Gempeler, Martín Rondón & Diego Rosselli

  3. Facultad de ciencias de la salud, Universidad Icesi, Cali, Colombia

    Alejandra Ortiz, Natalia Jaramillo & Jorge H. Mejía-Mantilla

  4. Fundación Valle del Lili, Cali, Colombia

    Luis Beltrán & Sara Escobar

  5. Department of Intensive Care Medicine, Fundación Valle del Lili, Cali, Colombia

    Jorge E. Martinez-Buitrago & Jorge H. Mejía-Mantilla

Authors
  1. Andrés Gempeler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leidy Gaviria
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alejandra Ortiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Natalia Jaramillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Luis Beltrán
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sara Escobar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Martín Rondón
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Diego Rosselli
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jorge E. Martinez-Buitrago
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jorge H. Mejía-Mantilla
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors made contributions to drafts of the manuscript and approved the final report. Conceiving the research question and developing the research protocol: JHM-M, AG, LG, AO, NJ, DR. Data collection: LG, LB, SE, AO, NJ. Statistical analysis: AG, JHM-M, MR. Interpretation of results: AG, LG, JHM-M, DR, AO, NJ, SE, LB, JEM-B.

Corresponding author

Correspondence to Andrés Gempeler.

Ethics declarations

Conflict of interest

No commercial or personal relations of the authors had a conflicted interest in the development of this work.

Ethical Approval/Informed Consent

The authors confirm compliance with ethical approval; informed consent was not required for this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 378 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gempeler, A., Gaviria, L., Ortiz, A. et al. Effect of an Albumin Infusion Treatment Protocol on Delayed Cerebral Ischemia and Relevant Outcomes in Patients with Subarachnoid Hemorrhage. Neurocrit Care 39, 180–190 (2023). https://doi.org/10.1007/s12028-023-01731-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-023-01731-3

Keywords

Search

Navigation